3 Min Read
(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stocks opened higher on Thursday as data on rising consumer spending and tightening labor market pointed to a recovery in the economy. The Dow Jones industrial average was up 0.15 percent at 17,992.29, the S&P 500 was up 0.12 percent at 2,111.03 and the Nasdaq Composite was up 0.12 percent at 5,128.
** CLEVELAND BIOLABS INC, $5.5, +94.35 pct
The drug developer signed a private placement agreement with David Davidovich, a venture capital investor, for sale of 6.4 million common shares at $3.87/share for $25 million.
** MAGNUM HUNTER RESOURCES CORP, $2.12, +21.14 pct
The oil and natural gas producer said it expected to raise $600-$700 million by selling its 45.53 percent stake in its natural gas gathering subsidiary, Eureka Hunter Holdings.
** IAC/INTERACTIVECORP, $80.47, +4.15 pct
The media company, controlled by media mogul Barry Diller, said it planned to list its dating business, which includes dating website Match.com and mobile dating app Tinder.
** VENAXIS INC, $0.4801, -13.65 pct
The diagnostic test maker said FDA reviewers needed more clinical data supporting revised intended use for blood testing system, APPY1. On Jan. 29, the agency did not find APPY1 to be "substantially equivalent" to standard of care.
** SUNEDISON SEMICONDUCTOR LTD, $18.555, -3.36 pct
The chip equipment maker's parent and top holder SunEdison Inc sold all but one share while Samsung Electronics Co Ltd, a joint venture partner, sold remaining interests.
** CREE INC, $27.2601, -10.80 pct
The company, which makes lighting and semiconductor products, said it would reduce manufacturing capacity at its light-emitting diode factory, as it struggles with a decline in prices, and take an $85 million restructuring charge.
** MERRIMACK PHARMACEUTICALS INC, $12.7299, +6.97 pct
The cancer drug developer says FDA grants priority review status to experimental cancer drug MM-398 and sets decision date for Oct. 24.
** WORLD ACCEPTANCE CORP, $68.13, -17.74 pct
The provider of loans to individuals' shares fell after brokerage FBR cut to "market perform" from "outperform, following the company's announcement on Wednesday it entered into ninth amendment to amended and restated revolving credit agreement.
** WINNEBAGO INDUSTRIES INC, $22.15, +7.00 pct
The largest U.S. motorhome maker reported better-than-expected quarterly revenue as it shipped more vehicles.
** ACCENTURE PLC, $99.87, +2.15 pct
The company raised its full-year revenue forecast for the third time, reflecting continued strong demand for the company's consulting and outsourcing services.
Compiled by Anya George Tharakan in Bengaluru; Editing by Sriraj Kalluvila